ArticleFrontiers in medicine2023

Efficacy and safety of novel carbapenem-β-lactamase inhibitor combinations: imipenem-cilastatin/relebactam results from randomized controlled trials.

Qingxin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.